why choose us

Clinical Trials Search

Showing 6,980 of 132,085 result(s)
Myo-Electrical and Nerve Root Function Response to Focused Extracorpeal Shock Wave in Cervical Radiculopathy

Status: Completed

Condition: Cervical Radiculopathy

Interventions: Focused Extracorporeal shock wave for 700 impulses of 0.056 mJ;mm at a frequency of 10 Hz to the taut band and 300 impulses surrounding the taut

Date: 2023-10-22

Feasibility of a Motor-cognitive Training Program in Patients With Traumatic Brain Injury

Status: COMPLETED

Condition: Traumatic Brain Injury

Interventions: The motor-cognitive training in this study will be conducted in form of a step-based dual-task training.
A mat (approximately 90 x 90 cm) made fr

Date: 2023-10-22

Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT

Status: Completed

Condition: EBV Infection After Allogenic HSCT

Interventions: The patients with EBV infection after HSCT will receive one to three infusions of donor-derived EBV-TCR-T cells, with the escalated dose ranging from

Date: 2023-10-21

Comparison of Different Methods for Determining Endotracheal Cuff Pressure

Status: COMPLETED

Condition: Anesthesia, General

Interventions: endotracheal tube cuff will be inflated via stethoscope guidance

Date: 2023-10-21

Development of MRF for Characterization of Brain Tumors After Radiotherapy

Status: NOT_YET_RECRUITING

Condition: Brain Tumor

Interventions: MRF in conjunction with IVIM MRI scan, without contrast.

Date: 2023-10-20

The Effect of Synaquell™ in Contact Sport Athletes

Status: Completed

Condition: Healthy

Interventions: 7.9 grams (1 scoop) of Synaquell powder mixed with 12 ounces of water two times per day for the duration of the sport season.
The daily amount ta

Date: 2023-10-20

A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Melanoma

Status: COMPLETED

Condition: Melanoma

Interventions: Participants treated with nivolumab +;- ipilimumab for unresectable;metastatic melanoma

Date: 2023-10-20

Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

Status: Completed

Condition: Chronic Obstructive Pulmonary Disease Exacerbation

Interventions:

EP395 (test product) oral capsule 125 mg.
Part A: Dose: 1 capsule as a single dose on Day 1 and Day 14, total daily dose: 125 mg.

Part B

Date: 2023-10-20

Effect of Adding Computerized Cognitive Training on Balance and Gait in Parkinson's Disease (Follow-up Study)

Status: Completed

Condition: Parkinson Disease

Interventions:

It is a computer-based cognitive rehabilitation test that includes 32 cognition training tasks for attention;concentration, reaction behavior,

Date: 2023-10-20

The Effectiveness of Sustained Heat Treatment on Delayed-Onset Muscle Soreness (DOMS)

Status: Completed

Condition: Delayed-Onset Muscle Soreness (DOMS)

Interventions: ThermaCare HeatWraps application

Date: 2023-10-20